Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Reasons Why You Should Retain Rollins Stock in Your Portfolio
Reasons Why You Should Retain Rollins Stock in Your Portfolio

Shares of Rollins, Inc. ROL have gained 30.6% over the past year, almost in line with the industry’s 30.5% growth.

The company’s fourth-quarter 2025 earnings are expected to increase 17.4% year over

PayPal's Agentic Commerce Expansion: Will it Boost Top-Line Growth?
PayPal's Agentic Commerce Expansion: Will it Boost Top-Line Growth?

PayPal Holdings PYPL announced a strategic partnership with Microsoft to power the rollout of Copilot Checkout in Copilot. This enables shoppers to discover, decide and pay entirely within the

Lindsay Q1 Earnings Beat Estimates, Revenues Decrease 6% Y/Y
Lindsay Q1 Earnings Beat Estimates, Revenues Decrease 6% Y/Y

Lindsay Corporation LNN delivered earnings per share of $1.54 in first-quarter fiscal 2026 (ended Nov. 30, 2025), beating the Zacks Consensus Estimate of $1.46. The bottom line decreased 2% year

TEM's Collab for Oncology Patient Population Is Gaining Attention
TEM's Collab for Oncology Patient Population Is Gaining Attention

Tempus AI TEM recently started working with leading academic medical centers to broaden access to advanced genomic testing and data-driven cancer care. In line with this, Tempus and NYU Langone

Will AbbVie's Oncology Segment Support Top-line Growth in Q4 Earnings?
Will AbbVie's Oncology Segment Support Top-line Growth in Q4 Earnings?

A meaningful portion of AbbVie’s ABBV revenues comes from its oncology franchise. Initially anchored by blood cancer drugs Imbruvica and Venclexta, the company has expanded its offerings into solid

3 Cruise Line Stocks in Focus on Expected Demand Strength in 2026
3 Cruise Line Stocks in Focus on Expected Demand Strength in 2026

The cruise industry is benefiting from strong demand for cruising and increased booking volumes. The industry is benefiting from solid bookings concerning North American and European sailings. Also

MKL Stock Trading at a Discount to Industry at 1.48X: Time to Hold?
MKL Stock Trading at a Discount to Industry at 1.48X: Time to Hold?

Markel Group Inc. MKL shares are trading at a discount compared with the Zacks Insurance - Multi-line industry. Its price-to-book ratio of 1.48X is lower than the industry average of 2.71X, the Fina

JPM's Q4 Earnings Beat Estimates on Solid Trading & NII, Weak IB Hurts
JPM's Q4 Earnings Beat Estimates on Solid Trading & NII, Weak IB Hurts

Impressive trading performance and higher net interest income (NII) drove JPMorgan’s JPM adjusted fourth-quarter 2025 earnings of $5.23 per share. The bottom line handily surpassed the Zacks

BNY Q4 Earnings Beat Estimates on Y/Y Growth in NII & Fee Income
BNY Q4 Earnings Beat Estimates on Y/Y Growth in NII & Fee Income

The Bank of New York Mellon Corporation’s BK fourth-quarter 2025 adjusted earnings of $2.08 per share surpassed the Zacks Consensus Estimate of $1.97. Also, the bottom line reflected a jump of 20.9%

Linie
10 predictions

Lindi
Account activated

ling9ling
10 predictions

LINGO54
Account activated

Linda23
Account activated

lin
First extensive comment

Linda1
Account activated